Content Reviewed By
Reviewed by a board-certified physician (Medical) · Reviewed by a licensed attorney specializing in mass tort litigation (Legal)
Tracking the FDA warnings, litigation progress, and medical research behind the Depo-Provera meningioma lawsuits. Updated as new developments emerge.
Over 1,700 cases filed and the statute of limitations is closing for some claimants. Here's the complete 2026 update on MDL 3140, key developments since August 2024, and your next steps.
Read More →Headaches, vision changes, hearing loss, cognitive shifts — if you've used Depo-Provera for 2+ years, these are the warning signs of meningioma to watch for, and when they require urgent care.
Read More →Used Depo-Provera for 2+ years and diagnosed with meningioma? Here's a plain-English eligibility breakdown, self-assessment checklist, and what to do if you think you have a claim.
Read More →Peer-reviewed research shows a 5.6x elevated meningioma risk in long-term Depo-Provera users. Here's the evidence trail — the BMJ study, how MPA drives tumor growth, and the FDA's response.
Read More →From gathering records to joining MDL 3140 — here's exactly what filing a Depo-Provera meningioma claim looks like, what it costs (nothing upfront), and how long it takes.
Read More →MDL 3140 is the federal consolidation of 1,700+ Depo-Provera meningioma cases. Here's what multidistrict litigation means, how the process works, and the realistic settlement timeline.
Read More →No Depo-Provera settlements announced yet — but comparable pharmaceutical MDLs give us realistic benchmarks. Here's what affects your case value and what to realistically expect.
Read More →Long-term Depo-Provera use is linked to bone density loss, delayed fertility, hormonal disruption, weight changes, mental health effects, and more — not just meningioma. Here's the full picture.
Read More →Diagnosed with meningioma after Depo-Provera use? Here's what to do first, how to stop safely, your treatment options, safe contraceptive alternatives, and how to build your medical team.
Read More →Many people search for a 'Depo-Provera class action' — but this is an MDL, and that difference directly affects your rights and potential recovery. Here's the plain-English explanation.
Read More →Over 1,700 cases filed. Bellwether selection underway. Here's the current litigation timeline, who the defendants are, and when settlements might realistically occur.
Read More →The FDA added a black box warning to Depo-Provera in August 2024. We break down what changed, who is at risk, and how the MPA concentration data supports the warning.
Read More →Stopping the shot does not reset your risk. Research shows elevated meningioma risk persists after discontinuation. Here's what the French cohort data shows and what it means legally.
Read More →If you used Depo-Provera for two or more years and were diagnosed with meningioma, you may qualify to file a claim. Check your eligibility now — it takes under 2 minutes.
Get a Free Case Review →